To the full analysis
Buyback calculator for Protagonist Therapeutics
Protagonist Therapeutics stock: key metrics
PTGXProtagonist Therapeutics had an operating margin of −343.6% and a return on invested capital (ROIC) of −76.9% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2014 | no data | no data | no data |
| 2015 | no data | no data | no data |
| 2016 | no data | no data | no data |
| 2017 | 100.0% | −188.9% | −184.2% |
| 2018 | 100.0% | −136.7% | −125.9% |
| 2019 | 100.0% | −34,857.6% | −33,414.3% |
| 2020 | 100.0% | −225.4% | −231.1% |
| 2021 | 100.0% | −460.0% | −458.9% |
| 2022 | 100.0% | −494.2% | −479.3% |
| 2023 | 100.0% | −156.1% | −131.6% |
| 2024 | 100.0% | 58.2% | 63.3% |
| 2025 | 97.3% | −343.6% | −282.8% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2014 | −100.0% | −82.0% | −100.0% |
| 2015 | −100.0% | no data | −100.0% |
| 2016 | 57.6% | −52.0% | −39.6% |
| 2017 | 36.4% | −28.7% | −22.6% |
| 2018 | 27.7% | −28.5% | −27.9% |
| 2019 | −96.5% | −54.6% | −49.8% |
| 2020 | −23.7% | −25.2% | −20.4% |
| 2021 | −41.8% | −33.8% | −36.1% |
| 2022 | −59.1% | −39.9% | −51.4% |
| 2023 | −23.5% | −26.7% | −22.1% |
| 2024 | 40.8% | 189.0% | 37.0% |
| 2025 | −21.2% | −76.9% | −19.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.